A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.
about
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle BiologyRAS-MAPK pathway epigenetic activation in cancer: miRNAs in actionMicroRNAs in heart failure: Small molecules with major impactRegulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAsDominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophyImproved risk stratification in prevention by use of a panel of selected circulating microRNAs.Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosisDeficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism.microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices.Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.Nutrition has a pervasive impact on cardiac microRNA expression in isogenic mice.Proteome modulation in H9c2 cardiac cells by microRNAs miR-378 and miR-378.Role of microRNAs in Vascular Remodeling.MicroRNAs in heart failure: new targets in disease management.Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke.Increased expression of microRNA-378a-5p in acute ethanol exposure of rat cardiomyocytes.Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.MicroRNAs: pleiotropic players in congenital heart disease and regeneration.microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.MicroRNAs in a hypertrophic heart: from foetal life to adulthood.Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy.Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloadingDefining miRNA targets: balancing simplicity with complexity.MicroRNA as a Therapeutic Target in Cardiac Remodeling.MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential.Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging.MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets.Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanical stress.
P2860
Q26770132-40F65A7F-C331-4B5F-B900-BBBE031EE627Q26773479-434531AA-0625-4ECD-815D-10366C7B25D1Q27024714-DDBCF195-DFF3-4C73-8C48-08888156A15EQ28072792-7CAE405B-FC2F-4F70-94F9-D517A5FA0104Q28266103-92D021A9-480E-4699-B419-EB2E3B497E3EQ33866958-EF9FE9F9-DE3D-47BD-8B65-93FE918D208DQ34089884-4D8FB457-B2EA-4C82-A600-7AF197316F78Q34245123-9A73E0EA-4B91-4221-A438-B7DA740E95C8Q35655378-C6442652-B9FC-4A4D-AE40-E12C375FE880Q35796556-05DDBDC7-9447-425C-BFE3-BA701AE36421Q36378208-ED522189-20C8-46BC-AB1E-CDB1EA15CA44Q37082696-A3A6FE99-796A-448C-AE6D-09DB24E3AC92Q37428826-366724F5-9626-4BF2-B365-3EAEDF76A49EQ37741544-FC381D45-2345-48BC-BCDC-868CBD666AB5Q38121484-CA6FA3F5-529E-4787-92E6-846059B2C137Q38153192-02450398-87B8-4AF3-80EE-341CF47DB66AQ38979695-557DC582-5821-48E1-8C41-04D7D8E03D59Q39201286-46B36DAB-1070-4A5B-863F-6DA1ED74BE54Q39265532-FE06FBA8-CB2D-43F1-8910-590932E26E70Q39403789-87405E1D-19AE-44CC-A320-51CF4D625F14Q39720055-7567D8E0-78B2-41DC-8198-6049C26E716CQ40001300-20B41AB1-0696-46F4-BFD1-0204F93F85CBQ41360125-BE0E5CCA-5F75-4369-8D19-DB9146E4C06EQ42566820-991A8B06-3931-404C-B196-8B349D1E7306Q44732086-51D20DB0-BC78-43D9-B2DB-0EAC68351030Q47644374-E18E5378-207E-4474-A3E7-D1EB820143B2Q47679651-C0D5A823-6D60-49C1-911F-DCB61AB46903Q50461881-E32EE6B5-6EC3-4C6E-AFE9-273717FADD01Q51293120-F9C1AD1A-CBA5-4B39-A6F3-8FBE4F850067Q52642353-7DBB2C17-480B-4CF6-8C50-DC8E8C396E92Q54979858-5C89AEB5-7F09-4930-A336-3277C4F4B4D1
P2860
A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@ast
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@en
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@nl
type
label
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@ast
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@en
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@nl
prefLabel
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@ast
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@en
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@nl
P2093
P2860
P356
P1476
A cardiac-enriched microRNA, m ...... hy by targeting Ras signaling.
@en
P2093
David L Geenen
Madhu Gupta
Mahesh P Gupta
Nagalingam R Sundaresan
R John Solaro
Raghu S Nagalingam
P2860
P304
11216-11232
P356
10.1074/JBC.M112.442384
P407
P577
2013-02-27T00:00:00Z